We are pleased to announce the release of Option Workbench 4.1. This release contains some exciting new data that will help you to create more flexible filters. Using the new volume and Put/Call...
By Lawrence G. McMillanThere was some positive action this week, but in the end it's still a trading range market. $SPX moved to the high end of the range almost challenging the all-time highs, but...
By Lawrence G. McMillanThese are two Exchange Traded Notes (ETN’s) that attempt to hedge a long “stock market” portfolio by using a long volatility component. We have written...
By Lawrence G. McMillanThe feature article is brief this time, but it is pertinent in that a potential buy signal has just set up in the Total put-call ratio – or has it? It doesn’t...
By Lawrence G. McMillanWe have very well-defined criteria for determining a major Total put-call ratio buy signal. These are powerful signals, worth a 100-point rise or more in $SPX. There have...
By Lawrence G. McMillanThe stock market has traded in an ever-narrowing range for over a month now. The most recent range has been bounded by 2090 on the upside and 2050 on the downside. But now $...
By Lawrence G. McMillan$SPX couldn't develop any momentum this week. Perhaps -- as the media were saying -- stocks were just waiting for the jobs report this morning. It was a very poor jobs report...
By Lawrence G. McMillanWe have taken a new (or have returned to an old) approach for earnings-related straddle buying recently, and that is the subject of the feature article. The article also...
By Lawrence G. McMillanWhen $SPX broke down through the 2090 support level, that was a very negative sign, especially since stocks failed at the old highs.There is now strong resistance at 2110-2120...
By Lawrence G. McMillanEveryone is aware of the fact that stocks gap sharply on certain news events – primarily earnings reports and, for biotechs, FDA-related news. Other events, such as...